 |
|
 |
 |
 |
| |
| COMPANY PROFILE |
 |
 |
PRODUCTS
& CUSTOMERS
Optima Chemical Group LLC
now sells to over 200
customers with a variety of
products, custom manufacturing, new
product development services and
toll manufacturing assets.
Capability now exists to produce
products with a wide range of
technologies with unique
capabilities in Organometallic
chemistries.
Several examples of these products
include Boronic Acids and Grignards.
Most recently Optima completed an
acquisition and licensing agreement
with FMC Lithium for manufacture of
a variety of specialty Organolithium,
Metal Hydrides, Organomagnesium,
Organosilanes, Organophosphine,
Alkylithium, Lithium Alkoxide,
Aryllithium, and Lithium Amide
products.
CURRENT
OPERATION
In May 1997, the majority of the
company’s equity was purchased by a
group of investors led by Charles A.
Hinnant, Charkit Chemical Corp.
Together with existing shareholders,
Optima Chemical Group LLC (OCG) was
formed.
Under the management of Charkit
Chemical Corp., much needed capital
was immediately infused.
Additionally marketing direction and
joint promotional efforts were
launched that resulted in
significant growth each year. The
plant has been completely redesigned
to function as a flexible, full
service, custom - toll manufacturing
facility. Critical equipment and
unit operations have been acquired
to expand the range of manufacturing
services offered. In addition, new
Laboratory facilities (R & D, Kilo,
and QC) and warehousing facilities
have been constructed. Critical
technical expertise needs have been
met through increases in
professional staffing. As business
opportunities continue to present
themselves, the need to expand
appears inevitable. For the present,
additional improvements continue to
be made to squeeze out more
capacity, create labor efficiencies,
and improve quality.
Also noteworthy, while under the
management of Charkit Chemical
Corp., Optima Chemical Group LLC
enjoys excellent performance in the
areas of Environmental, Health,
Safety and Security.
COMPANY
HISTORY
In the mid-1980’s, the US Dept. of
Energy (DOE) – Savannah River Site
(SRS) developed a process to treat
radioactive sludge waste produced
and stored at their Aiken, SC site.
The remediation process design
required a unique compound, Sodium
Tetraphenylborate (STPB), to
precipitate radioactive Cesium. STPB
was not commercially produced.
AFF, Inc. (AFF) partnered with a
research group at Georgia Tech, and
successfully developed a chemical
process to produce STPB.
Consequently, DuPont awarded AFF
with a contract for commercial
production of STPB. AFF did not have
the existing manufacturing
facilities to produce STPB and
purchased a closed Ethanol
production plant in Douglas, GA
around 1987 for that purpose, and
formed AFF – Chemical Division.
Major modifications to the plant
were required to produce STPB. The
manufacturing processes for Ethanol
and STPB were not similar in any
way. The plant was completely
redesigned, process equipment
purchased and installed to produce
STPB (and only STPB). AFF – Chemical
Division began routine commercial
production of STPB at this site in
April 1990 and ran continuously
until May 1991. At that time, SRS
requested production be halted for 6
months, because of delays in
remediation efforts at SRS.
During this time frame, the AFF name
and all AFF businesses, except the
Chemical Division, were sold In July
1991. The remaining Chemical
Division entity was renamed Optima
Chemical Inc (OCI).
In October 1991, SRS notified OCI
they were canceling the entire STPB
contract with OCI.
The contract cancellation was
devastating to OCI since there were
no other commercial markets for
STPB, and forced the company to
“reinvent” itself overnight. The
only reasonable option for survival
was to pursue contract or toll
manufacturing markets. This business
is normally an enormous undertaking
when properly planned for and
funded, and takes several years to
achieve profitability. OCI faced
this undertaking with no advance
planning, while bearing the burden
of debt incurred for entire STPB
plant. Further, the plant was not
completely equipped or set up for
contract / toll manufacturing, and
no name recognition had been
established in the markets being
entered. OCI struggled and survived,
with additional funding by
shareholders. During the 6 years OCI
operated, contract sales increased
from nothing to $2,700,000.
Gradually, improvements were made in
the plant design and equipment
additions / modifications. Business
opportunities steadily increased as
OCI began developing some name
recognition and a “portfolio” of
performance and continued until the
equity purchase in 1997.
|
| |
|
|
|
 |
 |
|
|
Copyright © 2010 Optima
Chemical Group, LLC. All rights reserved. |
|
|